CSIMarket
 


Kamada Ltd   (KMDA)
Other Ticker:  
 

Cumulative Kamada Ltd 's Quick Ratio for Trailing Twelve Months Period

KMDA's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

KMDA Quick Ratio for Trailing Twelve Months Period

(Dec 31 2023)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Current Liabilities Growth -34.49 % -34.49 % -34.49 % -34.49 % 40.05 %
Y / Y Cash & cash equivalent Growth 62.42 % 62.42 % 62.42 % 62.42 % 84.31 %
Quick Ratio for Trailing Twelve Months Period 1.12 0.9 0.72 0.57 0.45
Total Ranking # 726 # # # # 2844
Seq. Current Liabilities Growth 0 % 0 % 0 % -34.49 % 0 %
Seq. Cash & cash equivalent Growth 0 % 0 % 0 % 62.42 % 0 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Kamada Ltd Cash & cash equivalent average soared by 62.42% in IV. Quarter year on year, while Current Liabilities remained unchanged to $ 50 millions, this led to increase in in Kamada Ltd 's Quick Ratio for Trailing Twelve Months Period to 1.12, Quick Ratio for Trailing Twelve Months Period remained below Kamada Ltd average.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 148 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Kamada Ltd . While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about KMDA
Quick Ratio KMDA in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 149
Sector # 296
S&P 500 # 724


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
2.81 1.22 0.34
(Dec 31 2020)   (Dec 31 2021)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Tg Therapeutics Inc   3.05 
Eyenovia inc   3.03 
Immunogen inc   3.02 
Actinium Pharmaceuticals Inc   2.99 
Bio path Holdings inc   2.99 
Cartesian Therapeutics Inc   2.98 
Acurx Pharmaceuticals inc   2.96 
Innoviva Inc   2.94 
Arrowhead Pharmaceuticals Inc   2.94 
Casi Pharmaceuticals inc   2.93 
Enveric Biosciences Inc   2.90 
Marker Therapeutics inc   2.88 
Catalyst Pharmaceuticals Inc   2.84 
Neximmune Inc   2.83 
Inventiva S a   2.83 
Immunome Inc  2.81 
Axsome Therapeutics Inc   2.77 
Reviva Pharmaceuticals Holdings Inc   2.77 
Hookipa Pharma inc   2.75 
Galera Therapeutics Inc   2.74 
Scynexis Inc   2.72 
Tiziana Life Sciences Ltd  2.72 
Ardelyx Inc   2.71 
Insmed Inc  2.71 
Alnylam Pharmaceuticals Inc   2.69 
Cara Therapeutics inc   2.66 
Nls Pharmaceutics Ltd   2.66 
Ironwood Pharmaceuticals inc   2.64 
Macrogenics Inc   2.60 
Horizon Therapeutics Public Limited Company  2.55 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com